Related by context. Frequent words. (Click for all words.) 78 Phase III Clinical Trial 77 Patient Enrollment 74 Drug Candidate 74 Pivotal Phase III 74 Phase III Trial 73 Clinical Trial Results 73 Initiate Phase 72 FDA Accepts 72 Pivotal Trial 72 Completes Enrollment 71 Pivotal Phase 70 II Clinical Trial 70 Presents Positive 69 Generic Version 69 Patent Covering 68 Preclinical Data 68 Initiates Phase 67 Metastatic Melanoma 67 RNAi Therapeutics 67 Cervical Cancer Vaccine 66 Positive Opinion 66 Pulmonary Arterial Hypertension 66 Monoclonal Antibody 66 Chronic Hepatitis C 66 Malaria Vaccine 66 Cholesterol Drug 66 FDA Clears 65 Smallpox Vaccine 65 Cyclacel Pharmaceuticals 65 Recombinant Human 65 Transcept Pharmaceuticals 65 Cetrorelix 65 Benign Prostatic Hyperplasia 65 Tesetaxel 65 Drug Resistant 65 PHARM 65 Idera Pharmaceuticals 65 Gastric Cancer 65 Orphan Drug Status 65 Monotherapy 65 Well Tolerated 64 Study Demonstrates 64 Prostate Cancer Patients 64 Develop Novel 64 Ofatumumab 64 Chronic Lymphocytic Leukemia 64 Chronic Heart Failure 64 Exploit collaboration 64 Patients Treated 64 Clinical Study 64 FDA Orphan Drug 64 Small Molecule 64 Advanced Prostate Cancer 64 Clinical Trial 63 ACADIA Pharmaceuticals 63 Diabetic Macular Edema 63 Metastatic Colorectal Cancer 63 Inc Therapeutic Competitors 63 Cancer Vaccines 63 Daclizumab 63 THERAPEUTICS 63 Cethromycin 63 Phase IIIb 63 Panzem R 62 FDA Clearance 62 Combination Therapy 62 FDA Approves 62 Pirfenidone 62 Marketing Authorisation 62 Bird Flu Vaccine 62 Exclusive License 62 Shows Promise 62 refractory chronic lymphocytic 62 Receives Positive 62 Obstet Gynecol 62 Venous Thromboembolism 62 Blood Thinner 62 Influenza Vaccine 62 Cancer Vaccine 62 Phase Ib clinical 62 Elderly Patients 61 Laquinimod 61 Extended Release Tablets 61 Metabasis Therapeutics 61 BPAX 61 Kuvan R 61 Rexahn Pharmaceuticals 61 Allergic Rhinitis 61 Postmenopausal Women 61 Low Dose 61 Naproxcinod 61 Immunogenicity 61 submitted Biologics License 61 Patent Issued 61 Announces Initiation 61 Prostate Cancer Treatment 61 Vicor Technologies 61 Monoclonal Antibodies 61 Cancer Treatments 61 Reports Positive 61 Drug Eluting Stent